AWM Investment Company Inc. Sells 5,000 Shares of LeMaitre Vascular, Inc. $LMAT

Key Points

• AWM Investment Company Inc. reduced its stake in LeMaitre Vascular, Inc. by 3.3%, owning 145,000 shares valued at approximately $12.17 million after selling 5,000 shares.
• LeMaitre Vascular reported a 15% increase in quarterly revenue year-over-year, with earnings per share surpassing expectations at $0.60, compared to estimates of $0.57.
• The company declared a quarterly dividend of $0.20 per share, which reflects an annualized yield of 0.8%, with a payout ratio of 38.83%.

AWM Investment Company Inc. trimmed its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 3.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 145,000 shares of the medical instruments supplier's stock after selling 5,000 shares during the period. LeMaitre Vascular makes up 1.7% of AWM Investment Company Inc.'s portfolio, making the stock its 24th biggest holding. AWM Investment Company Inc. owned approximately 0.64% of LeMaitre Vascular worth $12,166,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of LMAT. Opal Wealth Advisors LLC bought a new stake in LeMaitre Vascular during the first quarter valued at about $26,000. NBC Securities Inc. acquired a new position in shares of LeMaitre Vascular during the first quarter valued at about $36,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of LeMaitre Vascular during the first quarter valued at about $50,000. US Bancorp DE raised its position in shares of LeMaitre Vascular by 36.0% during the first quarter. US Bancorp DE now owns 1,390 shares of the medical instruments supplier's stock valued at $117,000 after buying an additional 368 shares during the last quarter. Finally, Blueshift Asset Management LLC acquired a new position in shares of LeMaitre Vascular during the first quarter valued at about $232,000. 84.64% of the stock is currently owned by institutional investors.

Insider Activity at LeMaitre Vascular

In other news, Director John A. Roush sold 6,561 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $92.55, for a total transaction of $607,220.55. Following the sale, the director directly owned 2,916 shares of the company's stock, valued at $269,875.80. This represents a 69.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director David B. Roberts sold 10,815 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $92.39, for a total transaction of $999,197.85. Following the sale, the director directly owned 17,976 shares in the company, valued at $1,660,802.64. This trade represents a 37.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,815 shares of company stock valued at $11,280,206 over the last three months. 9.50% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Cantor Fitzgerald upped their price objective on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the company a "neutral" rating in a research report on Wednesday, August 6th. Barrington Research raised shares of LeMaitre Vascular from a "market perform" rating to an "outperform" rating and set a $95.00 price target for the company in a research report on Wednesday, August 6th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $97.60.

LeMaitre Vascular Price Performance

LeMaitre Vascular stock traded up $0.42 during trading hours on Friday, hitting $97.49. 140,809 shares of the stock were exchanged, compared to its average volume of 183,915. The company has a debt-to-equity ratio of 0.46, a quick ratio of 11.74 and a current ratio of 13.96. The stock has a market capitalization of $2.21 billion, a P/E ratio of 47.33, a P/E/G ratio of 2.51 and a beta of 0.79. LeMaitre Vascular, Inc. has a 12 month low of $71.42 and a 12 month high of $109.58. The business's 50-day moving average is $88.64 and its two-hundred day moving average is $86.20.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.57 by $0.03. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. The business had revenue of $63.15 million for the quarter, compared to analysts' expectations of $62.48 million. During the same period in the prior year, the firm earned $0.52 earnings per share. LeMaitre Vascular's revenue was up 15.0% compared to the same quarter last year. LeMaitre Vascular has set its Q3 2025 guidance at 0.540-0.590 EPS. FY 2025 guidance at 2.230-2.370 EPS. Equities research analysts expect that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 4th. Stockholders of record on Thursday, August 21st were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Thursday, August 21st. LeMaitre Vascular's dividend payout ratio is 38.83%.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.